Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 636 |
| Prevention | 199 |
| Diagnostic | 83 |
| Other | 37 |
| Supportive Care | 22 |
| Health Services Research | 21 |
| Screening | 21 |
| NA | 14 |
| Basic Science | 12 |
| Device Feasibility | 7 |
| Educational/Counseling/Training | 1 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 1679 |
| interventional | 1053 |
| Observational | 512 |
| Registry | 114 |
```
| intervention_type | Study_Count |
|---|---|
| Device | 254 |
| Drug | 218 |
| Procedure | 204 |
| Other | 95 |
| Drug|placebo | 86 |
| Behavioral | 48 |
| Device|Drug | 23 |
| Drug|Procedure | 22 |
| Device|Procedure | 18 |
| Device|Other | 14 |
| Diagnostic Test | 14 |
| Drug|Other | 11 |
| Behavioral|Other | 7 |
| Other|Procedure | 7 |
| Device|Drug|Procedure | 5 |
| Behavioral|Device | 3 |
| Diagnostic Test|Other | 2 |
| Dietary Supplement | 2 |
| Dietary Supplement|placebo | 2 |
| Drug|Other|Procedure | 2 |
| Drug|placebo|Procedure | 2 |
| Genetic | 2 |
| Behavioral|Drug | 1 |
| Behavioral|Genetic | 1 |
| Biological | 1 |
| Biological|Device | 1 |
| Biological|placebo | 1 |
| Combination Product | 1 |
| Device|Drug|Other | 1 |
| Device|Other|Procedure | 1 |
| Dietary Supplement|Drug|Other | 1 |
| Drug|Genetic | 1 |
| Drug|Other|placebo | 1 |
| placebo|Procedure | 1 |
| Country | Study_Count |
|---|---|
| United States | 253 |
| Canada | 77 |
| Germany | 51 |
| United Kingdom | 47 |
| NA | 45 |
| Korea, Republic of | 40 |
| France | 35 |
| China | 34 |
| Denmark | 27 |
| Italy | 25 |
| Netherlands | 22 |
| Japan | 20 |
| Spain | 20 |
| United States|Canada | 18 |
| Russian Federation | 17 |
| Norway | 14 |
| Sweden | 14 |
| Belgium | 11 |
| Brazil | 8 |
| Czechia | 7 |
| Finland | 7 |
| Switzerland | 7 |
| Israel | 6 |
| Poland | 6 |
| Taiwan | 6 |
| Austria | 5 |
| Australia | 4 |
| Czechia|France | 4 |
| Egypt | 4 |
| Greece | 4 |
| Hong Kong | 4 |
| Iran, Islamic Republic of | 4 |
| United States|Russian Federation | 4 |
| France|Germany | 3 |
| Australia|Canada | 2 |
| Belgium|Netherlands | 2 |
| Croatia|Czechia | 2 |
| Czech Republic | 2 |
| Czech Republic|Germany | 2 |
| Israel|Russian Federation | 2 |
| Lebanon | 2 |
| Malaysia | 2 |
| Netherlands|Spain | 2 |
| Turkey | 2 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|Italy|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 2 |
| United States|Belgium|Netherlands | 2 |
| United States|Canada|Korea, Republic of | 2 |
| United States|Germany | 2 |
| United States|Italy | 2 |
| United States|Netherlands | 2 |
| Argentina|Australia|Belgium|Croatia|France|Germany|Italy|Netherlands|Norway | 1 |
| Argentina|Brazil|China|India|Romania | 1 |
| Argentina|United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Russian Federation|Singapore|Slovakia|Slovenia|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom | 1 |
| Australia|Austria|Belgium|Canada|France|Germany | 1 |
| Australia|Austria|Belgium|Netherlands|Russian Federation|Slovakia|United Kingdom | 1 |
| Australia|Austria|Denmark|Germany|New Zealand|Spain|Switzerland | 1 |
| Australia|Austria|Estonia|Finland|France|Germany|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Portugal|Spain|Switzerland|Taiwan|United Kingdom | 1 |
| Australia|Austria|Germany|Hungary|Netherlands|Poland|Russian Federation|United Kingdom | 1 |
| Australia|Belgium|Bulgaria|Croatia|Czech Republic|Denmark|Estonia|Germany|Hungary|Lithuania|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Ukraine | 1 |
| Australia|Canada|China|Germany|Israel | 1 |
| Australia|Canada|Czech Republic|Denmark|Estonia|Finland|France|Germany|Latvia|Lithuania|Netherlands|Poland|Serbia|Slovakia|Sweden|Ukraine | 1 |
| Australia|France|Germany|Hong Kong|Italy | 1 |
| Australia|France|Germany|Italy|Portugal|United Kingdom | 1 |
| Australia|Germany|Malaysia|New Zealand|United Kingdom | 1 |
| Australia|Hong Kong|Singapore | 1 |
| Austria|Belgium|Canada|Czech Republic|Germany|Netherlands|Russian Federation|Slovakia | 1 |
| Austria|Belgium|Canada|Czechia|France|Hungary|Italy|Japan|Latvia|Netherlands|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Austria|Belgium|Czechia|Italy | 1 |
| Austria|Belgium|Denmark|France|Germany|Italy|Spain|Switzerland | 1 |
| Austria|Belgium|Denmark|France|Ireland|Italy|Netherlands|Switzerland|United Kingdom | 1 |
| Austria|Belgium|Finland|Germany|Greece|Ireland|Israel|Japan|Norway|Switzerland|United Kingdom | 1 |
| Austria|Belgium|France|Germany|Hungary|Italy|Korea, Republic of|Lithuania|Netherlands|Poland|Portugal|Romania|Serbia|Spain|Switzerland|Taiwan|Ukraine|United Kingdom | 1 |
| Austria|Czechia|France|Germany|Italy|Portugal|Spain | 1 |
| Austria|Germany|Netherlands | 1 |
| Belgium|Bulgaria|Croatia|Czechia|Denmark|Estonia|Hungary|Latvia|Lithuania|Poland|Russian Federation|Serbia|Slovakia|Spain|Ukraine | 1 |
| Belgium|Canada|Czechia|Germany|Hungary|Italy|Korea, Republic of|Poland|Spain|Taiwan|United Kingdom | 1 |
| Belgium|Canada|Czechia|Germany|Netherlands|United Kingdom | 1 |
| Belgium|Canada|Czechia|United Kingdom | 1 |
| Belgium|Canada|Denmark|France|Italy|Spain|Sweden | 1 |
| Belgium|Canada|Germany|Italy|Netherlands | 1 |
| Belgium|Czech Republic|Denmark|Finland|France|Germany|Hungary|Italy|Netherlands|Poland|Spain|United Kingdom | 1 |
| Belgium|Czech Republic|France|Italy|Netherlands|Poland|Spain|Sweden|Switzerland | 1 |
| Belgium|Czechia|Denmark|France|Germany|Italy | 1 |
| Belgium|Czechia|Denmark|France|Germany|Italy|Netherlands|Poland|Spain|Switzerland|United Kingdom | 1 |
| Belgium|Czechia|Denmark|Italy | 1 |
| Belgium|Czechia|Germany|Greece|Hungary|Israel|Spain | 1 |
| Belgium|Czechia|Germany|United Kingdom | 1 |
| Belgium|Czechia|Netherlands | 1 |
| Belgium|France|Germany|Hungary|Italy|Netherlands|Poland|Russian Federation|Spain | 1 |
| Belgium|France|Germany|Hungary|Netherlands|United Kingdom | 1 |
| Belgium|France|Germany|Italy|Spain|Switzerland|United Kingdom | 1 |
| Belgium|France|Germany|United Kingdom | 1 |
| Brazil|Canada|Sweden|Taiwan | 1 |
| Brazil|China|Germany|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Chile|Colombia|Czech Republic|Denmark|Finland|France|Greece|Hong Kong|Hungary|India|Israel|Korea, Republic of|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Peru|Philippines|Poland|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom|Venezuela | 1 |
| Bulgaria | 1 |
| Bulgaria|France|Germany|Poland|Russian Federation|Turkey|Ukraine | 1 |
| Canada|Chile|Czechia|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Denmark|France|Germany|Korea, Republic of|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|South Africa|Sweden|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| Canada|Czechia|Germany|Italy|Netherlands|United Kingdom | 1 |
| Canada|Germany | 1 |
| Canada|Germany|United Kingdom | 1 |
| Canada|Italy|Norway|Spain | 1 |
| China|Korea, Republic of|Singapore|Taiwan | 1 |
| Colombia|Czech Republic|Denmark|France|Germany|Mexico|Spain | 1 |
| Croatia | 1 |
| Croatia|Netherlands|New Zealand | 1 |
| Cyprus|Greece|Israel | 1 |
| Czech Republic|Denmark|Hungary|Netherlands|Norway|Poland|Slovakia|Sweden | 1 |
| Czech Republic|France|Italy|Netherlands|Serbia|Slovakia|United Kingdom | 1 |
| Czech Republic|Germany|Spain | 1 |
| Czechia|France|Germany|Hungary|Italy|Netherlands|Spain|Switzerland | 1 |
| Czechia|Germany | 1 |
| Czechia|Germany|Netherlands|Poland|United Kingdom | 1 |
| Czechia|Hungary|Italy|Poland|Spain | 1 |
| Czechia|Italy|United Kingdom | 1 |
| Czechia|Japan | 1 |
| Denmark|Finland|Germany|Hungary|Netherlands|Norway|Poland|Sweden | 1 |
| Denmark|Finland|Norway|Sweden | 1 |
| Denmark|Germany|Netherlands|Switzerland | 1 |
| Denmark|Netherlands | 1 |
| Denmark|Norway|Poland|Russian Federation|Slovakia|Sweden | 1 |
| Denmark|Norway|Poland|Russian Federation|Sweden|United Kingdom | 1 |
| Denmark|Norway|Sweden | 1 |
| Denmark|Russian Federation|Sweden | 1 |
| Denmark|Spain | 1 |
| Denmark|United States|Belgium|Brazil|Canada|China|Finland|France|Germany|Greece|Italy|Netherlands|Portugal|Singapore|South Africa|Spain|United Kingdom | 1 |
| Denmark|United States|Canada|Sweden | 1 |
| France|Australia|Austria|Bulgaria|Czech Republic|Estonia|Germany|Hungary|India|Israel|Japan|Korea, Republic of|Malaysia|Netherlands|Philippines|Poland|Russian Federation|Slovakia|South Africa|Spain|Thailand|Ukraine|United Kingdom | 1 |
| France|Germany|Greece | 1 |
| France|Germany|Spain|United Kingdom | 1 |
| France|Japan|Netherlands | 1 |
| France|United States|Belgium|Canada|Germany|Italy|Japan|Netherlands|Russian Federation|Spain|United Kingdom | 1 |
| Germany|Greece|Netherlands|Poland|Serbia|Switzerland|United Kingdom | 1 |
| Germany|Hungary|Spain | 1 |
| Germany|Italy|Spain|United Kingdom | 1 |
| Germany|Italy|Sweden | 1 |
| Germany|Spain|United Kingdom | 1 |
| Germany|Switzerland | 1 |
| Germany|United Kingdom | 1 |
| Germany|United States|Belgium|France|United Kingdom | 1 |
| Greece|Netherlands | 1 |
| Greece|Russian Federation | 1 |
| Hungary|Netherlands | 1 |
| Hungary|Ukraine|Bulgaria|Czechia | 1 |
| India | 1 |
| India|Israel|Italy|Poland|Portugal|Thailand|Turkey|Ukraine|France|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Denmark|Estonia|Finland|Germany|Greece|Guatemala|Hungary|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Peru|Philippines|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 1 |
| Ireland | 1 |
| Italy|Switzerland | 1 |
| Italy|United Kingdom | 1 |
| Italy|United States|Austria|Belgium|Bulgaria|Czechia|Denmark|France|Germany|Hungary|Israel|Netherlands|Poland|Romania|Russian Federation|Spain|Sweden|Ukraine|United Kingdom | 1 |
| Italy|United States|Austria|Belgium|Canada|France|Germany|Japan|Korea, Republic of|Netherlands|Poland|Spain|Switzerland|United Kingdom | 1 |
| Mexico | 1 |
| Netherlands|Switzerland|United Kingdom | 1 |
| Netherlands|United Kingdom | 1 |
| New Zealand|Singapore|Australia|Hong Kong|Japan|Korea, Republic of|Malaysia|South Africa|Taiwan|Thailand | 1 |
| Nigeria | 1 |
| Romania | 1 |
| Singapore | 1 |
| South Africa | 1 |
| Sweden|United Kingdom | 1 |
| Tunisia | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|India|Indonesia|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Czechia|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Canada|Chile|China|Czech Republic|Estonia|Finland|France|Germany|Italy|Korea, Republic of|Mexico|Morocco|Netherlands|Poland|Russian Federation|Sweden|Tunisia|Turkey | 1 |
| United States|Argentina|Australia|Austria|Belgium|Canada|Chile|China|Czech Republic|Finland|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Morocco|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|Thailand|Tunisia|Turkey|United Kingdom | 1 |
| United States|Argentina|Australia|Canada|Chile|Denmark|France|Germany|Hungary|Italy|Japan|Netherlands|Poland|Russian Federation|Spain|Sweden|Switzerland | 1 |
| United States|Argentina|Australia|Canada|South Africa | 1 |
| United States|Argentina|Belgium|Brazil|Canada|Denmark|Estonia|France|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Latvia|Mexico|Netherlands|New Zealand|Norway|Romania|Spain|Sweden|Taiwan|Thailand|United Kingdom | 1 |
| United States|Argentina|Canada|Chile|Denmark|Mexico|Sweden | 1 |
| United States|Argentina|Canada|Denmark|India|Poland | 1 |
| United States|Argentina|Canada|Denmark|South Africa|Sweden | 1 |
| United States|Argentina|Czech Republic|Former Serbia and Montenegro|Germany|Israel|Poland|Romania|Russian Federation|Slovakia|South Africa|Ukraine|United Kingdom | 1 |
| United States|Australia | 1 |
| United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|Sweden|Switzerland|Taiwan|Thailand|United Kingdom | 1 |
| United States|Australia|Belgium|France|Germany|Netherlands|Spain | 1 |
| United States|Australia|Brazil|Canada|India|Israel|Latvia|Lithuania|Poland|Russian Federation|South Africa|Ukraine|United Kingdom | 1 |
| United States|Australia|Canada | 1 |
| United States|Australia|Canada|China|Czechia|Germany|Italy|Korea, Republic of|Russian Federation|United Kingdom | 1 |
| United States|Australia|Canada|Denmark|France|Italy|Netherlands|New Zealand|Poland|United Kingdom | 1 |
| United States|Australia|Canada|Netherlands | 1 |
| United States|Australia|Czechia|France|Germany|Portugal|Spain|Sweden|United Kingdom | 1 |
| United States|Australia|Germany|Italy | 1 |
| United States|Austria|Belgium|Denmark|Germany|Italy|Netherlands|Spain|United Kingdom | 1 |
| United States|Austria|Canada|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom | 1 |
| United States|Austria|Denmark|Germany|Greece|Italy|Japan|Netherlands|Norway|Spain|Switzerland|United Kingdom | 1 |
| United States|Austria|Germany|Italy|Netherlands|Slovenia|Spain | 1 |
| United States|Belarus|Belgium|Bosnia and Herzegovina|Canada|Chile|Latvia|Mexico|Moldova, Republic of|Russian Federation|Slovakia|Ukraine | 1 |
| United States|Belgium|Canada|Czechia|Denmark|Germany|Hungary|Italy|Netherlands|Norway|Spain|Switzerland|United Kingdom | 1 |
| United States|Belgium|Canada|Denmark|Germany|Israel|Italy|Japan|Korea, Republic of|Romania|Spain|Sweden | 1 |
| United States|Belgium|Germany | 1 |
| United States|Belgium|Germany|Netherlands | 1 |
| United States|Brazil|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|China|Colombia|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom | 1 |
| United States|Brazil|Canada|Czechia|Italy | 1 |
| United States|Bulgaria|Germany|Hungary|Italy|Poland | 1 |
| United States|Canada|China|Spain | 1 |
| United States|Canada|Czech Republic|France|Germany|Hungary|Italy|Netherlands|Portugal | 1 |
| United States|Canada|Czechia|France|Italy | 1 |
| United States|Canada|Czechia|Germany|Italy | 1 |
| United States|Canada|Denmark|Netherlands | 1 |
| United States|Canada|Germany | 1 |
| United States|Canada|Hungary|Netherlands|Poland|Serbia | 1 |
| United States|Canada|Japan | 1 |
| United States|Colombia | 1 |
| United States|Colombia|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Peru|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|Spain|Sweden|Switzerland|Ukraine|United Kingdom|Virgin Islands (U.S.) | 1 |
| United States|Czech Republic|Germany | 1 |
| United States|Czech Republic|Poland|Russian Federation|Ukraine | 1 |
| United States|Czechia|France|Italy | 1 |
| United States|Czechia|Germany | 1 |
| United States|Czechia|Russian Federation | 1 |
| United States|Denmark|Sweden | 1 |
| United States|France|Switzerland | 1 |
| United States|Germany|Israel|Italy|Netherlands|Poland|United Kingdom | 1 |
| United States|Germany|Netherlands | 1 |
| United States|Greece|Russian Federation | 1 |
| United States|Hungary|Italy|Saudi Arabia|Slovakia|South Africa|United Kingdom | 1 |
| United States|Israel | 1 |
| United States|Japan | 1 |
| United States|Puerto Rico | 1 |
| United States|United Kingdom | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 626 |
| 2 | 77 |
| 3 | 41 |
| 4 | 29 |
| 5 | 14 |
| 6 | 16 |
| 7 | 16 |
| 8 | 10 |
| 9 | 9 |
| 10 | 14 |
| 11 | 8 |
| 12 | 13 |
| 13 | 5 |
| 14 | 3 |
| 15 | 11 |
| 16 | 6 |
| 17 | 6 |
| 18 | 9 |
| 19 | 7 |
| 20 | 6 |
| 21 | 5 |
| 22 | 5 |
| 23 | 7 |
| 24 | 5 |
| 25 | 4 |
| 26 | 5 |
| 27 | 1 |
| 28 | 5 |
| 29 | 2 |
| 30 | 5 |
| 31 | 3 |
| 32 | 2 |
| 33 | 1 |
| 34 | 2 |
| 35 | 1 |
| 36 | 2 |
| 37 | 2 |
| 38 | 5 |
| 39 | 2 |
| 40 | 4 |
| 41 | 1 |
| 44 | 3 |
| 49 | 2 |
| 51 | 1 |
| 53 | 1 |
| 54 | 2 |
| 57 | 2 |
| 58 | 2 |
| 60 | 1 |
| 62 | 1 |
| 64 | 1 |
| 67 | 2 |
| 75 | 1 |
| 81 | 1 |
| 82 | 1 |
| 84 | 1 |
| 87 | 1 |
| 91 | 1 |
| 97 | 1 |
| 100 | 1 |
| 101 | 1 |
| 103 | 2 |
| 111 | 1 |
| 113 | 1 |
| 114 | 1 |
| 116 | 1 |
| 118 | 1 |
| 127 | 1 |
| 129 | 1 |
| 130 | 1 |
| 132 | 1 |
| 152 | 1 |
| 165 | 2 |
| 170 | 1 |
| 178 | 2 |
| 200 | 1 |
| 223 | 1 |
| 230 | 2 |
| 233 | 1 |
| 356 | 1 |
| 421 | 1 |
| 503 | 1 |
| 567 | 1 |
| 626 | 1 |
| 959 | 1 |
| 984 | 1 |
| 1016 | 1 |
| 1113 | 1 |
| Phase | Study_Count |
|---|---|
| N/A | 609 |
| Phase 4 | 173 |
| Phase 3 | 145 |
| Phase 2 | 86 |
| Phase 1 | 17 |
| Phase 2/Phase 3 | 12 |
| Phase 1/Phase 2 | 7 |
| Early Phase 1 | 4 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 212 |
| 2 | 651 |
| 3 | 74 |
| 4 | 40 |
| 5 | 5 |
| 6 | 4 |
| 7 | 1 |
| 8 | 1 |
| 9 | 1 |
| 10 | 1 |
| 11 | 1 |
| NA | 62 |
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 10.0 | 1.000 | 13.00000 | 13.0 | 3.0000 | 48.0000 | 5.000 | 10.0000 |
| 1st Qu. | 17.5 | 60.000 | 20.00000 | 23.0 | 50.0000 | 60.0000 | 120.000 | 80.0000 |
| Median | 30.0 | 122.000 | 40.00000 | 50.0 | 130.0000 | 205.0000 | 253.500 | 176.0000 |
| Mean | 30.0 | 4307.916 | 60.94118 | 62.0 | 220.7882 | 280.8333 | 1368.907 | 768.4566 |
| 3rd Qu. | 42.5 | 300.000 | 58.00000 | 97.5 | 234.0000 | 431.0000 | 659.250 | 398.0000 |
| Max. | 50.0 | 1260576.000 | 280.00000 | 130.0 | 1280.0000 | 800.0000 | 21105.000 | 52000.0000 |
| group_type | Group_Count |
|---|---|
| Experimental | 874 |
| Active Comparator | 709 |
| Other | 147 |
| No Intervention | 145 |
| Placebo Comparator | 108 |
| NA | 62 |
| Sham Comparator | 7 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 752 |
| Single Group Assignment | 250 |
| Crossover Assignment | 30 |
| Factorial Assignment | 11 |
| Sequential Assignment | 5 |
| NA | 5 |
| primary_purpose | Study_Count |
|---|---|
| Treatment | 636 |
| Prevention | 199 |
| Diagnostic | 83 |
| Other | 37 |
| Supportive Care | 22 |
| Health Services Research | 21 |
| Screening | 21 |
| NA | 14 |
| Basic Science | 12 |
| Device Feasibility | 7 |
| Educational/Counseling/Training | 1 |
| Country | Study_Count |
|---|---|
| United States | 113 |
| NA | 50 |
| France | 35 |
| Germany | 35 |
| Spain | 22 |
| United Kingdom | 22 |
| China | 17 |
| Korea, Republic of | 17 |
| Canada | 16 |
| Sweden | 15 |
| Finland | 13 |
| Italy | 11 |
| Japan | 11 |
| Switzerland | 10 |
| Denmark | 8 |
| Netherlands | 8 |
| Greece | 6 |
| Norway | 6 |
| Belgium | 5 |
| Russian Federation | 5 |
| Taiwan | 5 |
| Turkey | 5 |
| Poland | 4 |
| Austria | 3 |
| Germany|Netherlands | 3 |
| Germany|Switzerland | 3 |
| Israel | 3 |
| Thailand | 3 |
| Argentina | 2 |
| Korea, Republic of|Taiwan | 2 |
| United States|Puerto Rico | 2 |
| Argentina|Azerbaijan|Bahrain|Chile|Colombia|Egypt|Georgia|Jordan|Kazakhstan|Kenya|Lebanon|Mexico|Russian Federation|Saudi Arabia|United Arab Emirates|Uruguay|Venezuela | 1 |
| Argentina|Canada|Chile|Germany|Italy|Spain | 1 |
| Australia | 1 |
| Australia|Austria|France|Italy|Portugal|South Africa | 1 |
| Australia|Belgium|Canada|France|Germany|Italy|Monaco|United Kingdom | 1 |
| Australia|China|Hong Kong|Korea, Republic of|Malaysia|Philippines|Taiwan|Thailand | 1 |
| Austria|Belarus|Czech Republic|Finland|Germany|Italy|Netherlands|Portugal|Russian Federation|Slovakia|Slovenia|Spain|Sweden|Switzerland|United Arab Emirates|United Kingdom | 1 |
| Austria|Belgium|Bulgaria|Croatia|Czechia|Denmark|Estonia|France|Germany|Greece|Ireland|Italy|Latvia|Netherlands|Norway|Poland|Portugal|Romania|Slovenia|Spain|Sweden|United Kingdom | 1 |
| Austria|Bulgaria|Czechia|Estonia|Hungary|Israel|Latvia|Poland|Romania|Russian Federation|Serbia|Slovenia | 1 |
| Austria|Denmark|Finland|Germany|Spain|Sweden | 1 |
| Belgium|Denmark|Greece|Netherlands|Norway|Portugal|Sweden | 1 |
| Belgium|Ireland|Italy|Netherlands|Portugal|Spain | 1 |
| Bulgaria|Czech Republic|Denmark|France|Germany|Slovakia|Spain|United Kingdom | 1 |
| Bulgaria|France|Germany|Poland|Russian Federation|Turkey|Ukraine | 1 |
| Canada|Netherlands | 1 |
| Canada|Sweden | 1 |
| Colombia | 1 |
| Czech Republic|United Kingdom | 1 |
| Czechia | 1 |
| Czechia|France|Germany|Netherlands|Spain|Switzerland | 1 |
| Denmark|France|Germany|Ireland|Italy|Netherlands|Poland|Spain|United Kingdom | 1 |
| Denmark|Germany|Hong Kong|Ireland|Italy|Poland|Spain|Sweden|Thailand | 1 |
| Egypt | 1 |
| France|Italy|Switzerland | 1 |
| Germany|China|Croatia|Egypt|Lebanon|Netherlands|Spain|Turkey | 1 |
| Germany|France|Hungary | 1 |
| Hong Kong | 1 |
| Hong Kong|India|Indonesia|Korea, Republic of|Malaysia|Pakistan|Philippines|Singapore|Taiwan|Thailand|Vietnam | 1 |
| Hong Kong|India|Korea, Republic of|Singapore|Taiwan|Thailand | 1 |
| India | 1 |
| Indonesia|Korea, Republic of|Malaysia|Singapore|Thailand | 1 |
| Ireland | 1 |
| Jordan | 1 |
| Lithuania | 1 |
| Puerto Rico | 1 |
| Romania | 1 |
| Slovakia | 1 |
| Slovenia|Sweden|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hungary|Ireland|Israel|Moldova, Republic of|Netherlands|Norway|Poland|Portugal|Russian Federation|Slovakia|Ukraine|United Kingdom | 1 |
| Tunisia | 1 |
| United States|Argentina|Brazil|Canada|Chile|China|Colombia|Ecuador|Hong Kong|Japan|Korea, Republic of|Lebanon|Mexico|Peru|Russian Federation|Saudi Arabia|Singapore|South Africa|Taiwan|United Arab Emirates|Venezuela | 1 |
| United States|Australia|Belgium|France|Germany|Netherlands|Spain | 1 |
| United States|Australia|Canada | 1 |
| United States|Australia|France | 1 |
| United States|Belgium|Canada|Greece|Netherlands | 1 |
| United States|Canada | 1 |
| United States|Germany|Israel|United Kingdom | 1 |
| United States|Greece | 1 |
| United States|Monaco | 1 |
| United States|Netherlands | 1 |
| United States|New Zealand | 1 |
| United States|Puerto Rico|Virgin Islands (U.S.) | 1 |
| Venezuela | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 378 |
| 2 | 33 |
| 3 | 15 |
| 4 | 11 |
| 5 | 5 |
| 6 | 6 |
| 7 | 4 |
| 8 | 6 |
| 9 | 6 |
| 10 | 1 |
| 11 | 1 |
| 12 | 1 |
| 13 | 4 |
| 15 | 1 |
| 16 | 1 |
| 17 | 2 |
| 18 | 1 |
| 19 | 2 |
| 21 | 3 |
| 22 | 3 |
| 23 | 1 |
| 24 | 2 |
| 26 | 1 |
| 27 | 1 |
| 28 | 1 |
| 29 | 1 |
| 32 | 1 |
| 39 | 1 |
| 40 | 1 |
| 42 | 1 |
| 45 | 1 |
| 47 | 1 |
| 50 | 1 |
| 55 | 1 |
| 56 | 1 |
| 62 | 1 |
| 75 | 1 |
| 100 | 1 |
| 140 | 1 |
| 148 | 1 |
| 161 | 1 |
| 171 | 1 |
| 220 | 1 |
| 523 | 1 |
| 666 | 1 |
| 1164 | 1 |
| 1616 | 1 |
| Measure | Observational |
|---|---|
| Min | 5.00 |
| 1st Qu | 100.00 |
| Median | 364.00 |
| Mean | 13398.68 |
| 3rd Qu | 1766.00 |
| Max | 814446.00 |
| observational_model | Study_Count |
|---|---|
| Cohort | 347 |
| Case-Only | 62 |
| Case-Control | 31 |
| Other | 27 |
| Case Control | 19 |
| NA | 19 |
| Case-Crossover | 3 |
| Ecologic or Community | 3 |
| Defined Population, Natural History | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 338 |
| Retrospective | 128 |
| Cross-Sectional | 30 |
| Other | 9 |
| NA | 6 |
| Longitudinal, Retrospective | 1 |
| Country | Study_Count |
|---|---|
| United States | 18 |
| NA | 11 |
| Italy | 9 |
| Germany | 8 |
| Korea, Republic of | 6 |
| Canada | 5 |
| China | 4 |
| France | 4 |
| Egypt | 3 |
| Poland | 3 |
| Russian Federation | 3 |
| Spain | 3 |
| Finland | 2 |
| Netherlands | 2 |
| Singapore | 2 |
| Sweden | 2 |
| Switzerland | 2 |
| Australia|Belgium|Chile|Denmark|Finland|France|Germany|Ireland|Israel|Italy|Netherlands|Norway|Poland|Spain|Sweden|United Kingdom | 1 |
| Australia|Hong Kong|Indonesia|Korea, Republic of|Malaysia|Saudi Arabia|Thailand | 1 |
| Austria | 1 |
| Austria|Belgium|France|Germany|Switzerland | 1 |
| Austria|Denmark|Sweden | 1 |
| Austria|Germany | 1 |
| Belgium | 1 |
| Belgium|Austria|Canada|China|Czechia|France|Germany|India|Italy|Korea, Republic of|Netherlands|Portugal|Saudi Arabia|Spain|United Kingdom | 1 |
| Belgium|France|Germany|Ireland|Italy|Netherlands|Poland|Portugal|Russian Federation|Saudi Arabia|Spain|United Arab Emirates|United Kingdom | 1 |
| Belgium|Netherlands | 1 |
| Brazil | 1 |
| China|Hong Kong|Japan|Korea, Republic of|Taiwan | 1 |
| Colombia | 1 |
| Czechia|Germany|Ireland|Spain|United Kingdom | 1 |
| Denmark | 1 |
| France|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom | 1 |
| France|United Kingdom | 1 |
| Greece | 1 |
| Indonesia | 1 |
| Israel | 1 |
| Japan | 1 |
| Latvia | 1 |
| Mexico|United States|Argentina|Austria|Belgium|Brunei Darussalam|Chile|China|Colombia|Czechia|Germany|Greece|Hungary|Iceland|Indonesia|Italy|Japan|Kazakhstan|Korea, Republic of|Kuwait|Malaysia|Oman|Philippines|Poland|Portugal|Russian Federation|Saudi Arabia|Serbia|Singapore|Slovakia|South Africa|Spain|Switzerland|Taiwan|Thailand|United Arab Emirates|United Kingdom | 1 |
| Netherlands|Russian Federation | 1 |
| Tunisia | 1 |
| Turkey | 1 |
| United Kingdom | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 80 |
| 2 | 7 |
| 3 | 2 |
| 4 | 3 |
| 9 | 4 |
| 12 | 1 |
| 13 | 1 |
| 15 | 1 |
| 16 | 1 |
| 20 | 1 |
| 21 | 2 |
| 25 | 1 |
| 41 | 1 |
| 47 | 1 |
| 51 | 1 |
| 62 | 2 |
| 90 | 1 |
| 91 | 1 |
| 98 | 1 |
| 125 | 1 |
| 154 | 1 |
| Measure | Registries |
|---|---|
| Min | 1.0 |
| 1st Qu | 250.0 |
| Median | 905.0 |
| Mean | 119954.8 |
| 3rd Qu | 2163.5 |
| Max | 7205000.0 |
| observational_model | Study_Count |
|---|---|
| Cohort | 83 |
| Case-Only | 16 |
| Case-Control | 6 |
| Other | 5 |
| Ecologic or Community | 2 |
| Case-Crossover | 1 |
| NA | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 104 |
| Other | 5 |
| Cross-Sectional | 3 |
| Retrospective | 1 |
| NA | 1 |
| target_duration | Study_Count |
|---|---|
| 12 Months | 21 |
| 1 Year | 16 |
| 2 Years | 14 |
| 5 Years | 11 |
| 1 Day | 8 |
| 3 Years | 8 |
| 10 Years | 5 |
| 24 Months | 5 |
| 1 Month | 4 |
| 18 Months | 2 |
| 3 Months | 2 |
| 30 Days | 2 |
| 6 Months | 2 |
| 105 Months | 1 |
| 12 Weeks | 1 |
| 15 Years | 1 |
| 17 Years | 1 |
| 2 Days | 1 |
| 3 Days | 1 |
| 36 Months | 1 |
| 4 Months | 1 |
| 4 Weeks | 1 |
| 4 Years | 1 |
| 60 Days | 1 |
| 60 Months | 1 |
| 8 Weeks | 1 |
| 90 Days | 1 |
#If less then 500 trials
#If less then 500 studies
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT03389074 | Evaluation of Optimal Ablation Index for Pulmonary Vein Isolation in Patients With AF Prospective Registry | https://ClinicalTrials.gov/show/NCT03389074 | Active, not recruiting | Seoul National University Hospital | 2019-09-09 |
| NCT03362788 | The Greek AntiPlatElet Atrial Fibrillation Registry. | https://ClinicalTrials.gov/show/NCT03362788 | Recruiting | Attikon Hospital | 2020-06-30 |
| NCT03303872 | Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) | https://ClinicalTrials.gov/show/NCT03303872 | Recruiting | Yonsei University | 2019-12-31 |
| NCT03279406 | REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion | https://ClinicalTrials.gov/show/NCT03279406 | Completed | University Hospital, Tours | 2018-06-01 |
| NCT03277976 | Pulmonary Vein Isolation Guided by Ablation Index (Ablation Index Registry Study) | https://ClinicalTrials.gov/show/NCT03277976 | Active, not recruiting | Clinica Mediterranea | 2018-09-28 |
| NCT03272620 | Atrial Fibrillation at the Viennese University Emergency Department | https://ClinicalTrials.gov/show/NCT03272620 | Recruiting | Medical University of Vienna | 2020-01-01 |
| NCT03223207 | CareLink Express (CLE Research) | https://ClinicalTrials.gov/show/NCT03223207 | Completed | Baylor Research Institute | 2018-08-27 |
| NCT03188484 | Atrial Fibrillation Research In CATalonia | https://ClinicalTrials.gov/show/NCT03188484 | Recruiting | Jordi Gol i Gurina Foundation | 2017-04-30 |
| NCT03091452 | CArdioSurgEry Atrial Fibrillation Register | https://ClinicalTrials.gov/show/NCT03091452 | Recruiting | Stiftung Institut fuer Herzinfarktforschung | 2019-12-31 |
| NCT03085576 | NATional TUnisian REgistry of Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT03085576 | Completed | Dacima Consulting | 2018-05-30 |
| NCT03075930 | Atrial Fibrillation Ablation Registry | https://ClinicalTrials.gov/show/NCT03075930 | Recruiting | Maastricht University Medical Center | 2022-01-31 |
| NCT03051061 | Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT03051061 | Recruiting | Henan Institute of Cardiovascular Epidemiology | 2019-12-01 |
| NCT03041233 | ABLATOR Brazil - Ablation Observational Study (Registry) | https://ClinicalTrials.gov/show/NCT03041233 | Active, not recruiting | Abbott Medical Devices | 2020-04-27 |
| NCT03040037 | Cryoballoon Atrial Fibrillation Ablation Registry | https://ClinicalTrials.gov/show/NCT03040037 | Recruiting | Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 2020-07-01 |
| NCT03014557 | China REgistry of WATCHMAN | https://ClinicalTrials.gov/show/NCT03014557 | Recruiting | Fu Wai Hospital, Beijing, China | 2023-12-31 |
| NCT03004859 | Opportunistic Screening in Pharmacies for Atrial Fibrillation in Seniors (>65 Years) | https://ClinicalTrials.gov/show/NCT03004859 | Completed | RWTH Aachen University | 2018-08-22 |
| NCT02978248 | ARENA - Project Atrial Fibrilation Rhine-Neckar Region | https://ClinicalTrials.gov/show/NCT02978248 | Recruiting | Stiftung Institut fuer Herzinfarktforschung | 2018-12-31 |
| NCT02950168 | Edoxaban Management in Diagnostic and Therapeutic Procedures | https://ClinicalTrials.gov/show/NCT02950168 | Completed | Daiichi Sankyo, Inc. | 2018-07-26 |
| NCT02893215 | Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study) | https://ClinicalTrials.gov/show/NCT02893215 | Recruiting | Hvidovre University Hospital | 2018-09-30 |
| NCT02830750 | Low Fluoroscopy Afib Ablation Registry | https://ClinicalTrials.gov/show/NCT02830750 | Completed | Stanford University | 2018-04-30 |
| NCT02790801 | The First Russian Observational Survey of Heart Failure Patients With Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT02790801 | Completed | Federal State Budgetary Scientific Institution, Research Institute of Cardiology | 2017-05-31 |
| NCT02752737 | Cryo AF Global Registry | https://ClinicalTrials.gov/show/NCT02752737 | Active, not recruiting | Medtronic Cardiac Rhythm and Heart Failure | 2022-12-31 |
| NCT02743416 | Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II | https://ClinicalTrials.gov/show/NCT02743416 | Active, not recruiting | Karolinska University Hospital | 2023-04-30 |
| NCT02741349 | Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT02741349 | Recruiting | Saint Antoine University Hospital | 2021-12-31 |
| NCT02663076 | Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry | https://ClinicalTrials.gov/show/NCT02663076 | Recruiting | GWT-TUD GmbH | 2020-12-31 |
| NCT02635230 | What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. | https://ClinicalTrials.gov/show/NCT02635230 | Recruiting | R&D Cardiologie | 2021-01-31 |
| NCT02587624 | Remote MAGNetic Catheter Ablation for Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT02587624 | Recruiting | Paracelsus Medical University | 2017-12-31 |
| NCT02699957 | Left Atrial Appendage Occlusion Registry (LAAO Registry) | https://ClinicalTrials.gov/show/NCT02699957 | Recruiting | American College of Cardiology | 2026-01-31 |
| NCT02565238 | BIO.MASTER.BioMonitor 2 Study | https://ClinicalTrials.gov/show/NCT02565238 | Completed | Biotronik SE & Co. KG | 2016-10-31 |
| NCT02563639 | Apixaban in Atrial Fibrillation Registry | https://ClinicalTrials.gov/show/NCT02563639 | Completed | IHF GmbH - Institut für Herzinfarktforschung | 2018-08-31 |
| NCT02533752 | Canadian WATCHMAN Registry | https://ClinicalTrials.gov/show/NCT02533752 | Recruiting | Cardiology Research UBC | 2020-09-30 |
| NCT02518984 | Atrial Fibrillation General Registry | https://ClinicalTrials.gov/show/NCT02518984 | Completed | European Society of Cardiology | 2019-08-31 |
| NCT02516033 | Hybrid Atrial Fibrillation Ablation Registry | https://ClinicalTrials.gov/show/NCT02516033 | Enrolling by invitation | University Medical Center Groningen | 2021-01-31 |
| NCT02507856 | Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA | https://ClinicalTrials.gov/show/NCT02507856 | Recruiting | University Hospital, Essen | 2021-06-30 |
| NCT02485288 | PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort | https://ClinicalTrials.gov/show/NCT02485288 | Active, not recruiting | University of Pittsburgh | 2020-09-30 |
| NCT02461602 | Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients | https://ClinicalTrials.gov/show/NCT02461602 | Completed | Duke University | 2018-05-31 |
| NCT02447081 | Amplatzerâ„¢Amuletâ„¢ Post-Market Study (Amuletâ„¢PMS) | https://ClinicalTrials.gov/show/NCT02447081 | Completed | Abbott Medical Devices | 2018-10-23 |
| NCT02433613 | Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry) | https://ClinicalTrials.gov/show/NCT02433613 | Completed | Medtronic Cardiac Rhythm and Heart Failure | 2018-11-20 |
| NCT02366338 | PRescriptiOn PattERns Of Oral Anticoagulants | https://ClinicalTrials.gov/show/NCT02366338 | Completed | Muğla Sıtkı Koçman University | 2014-11-30 |
| NCT02349269 | Postoperative Atrial Fibrillation and Long-term Survival | https://ClinicalTrials.gov/show/NCT02349269 | Completed | Kuopio University Hospital | 2012-12-31 |
| NCT02344173 | ABLATOR Ablation Observational Registry | https://ClinicalTrials.gov/show/NCT02344173 | Completed | Abbott Medical Devices | 2017-08-18 |
| NCT02344901 | ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES) | https://ClinicalTrials.gov/show/NCT02344901 | Completed | Muğla Sıtkı Koçman University | 2015-04-30 |
| NCT02334852 | Registry of Atrial Fibrillation and Embolic Risk in Mexico | https://ClinicalTrials.gov/show/NCT02334852 | Completed | Registro de Fibrilación Auricular y Riesgo Embólico en México | 2016-12-31 |
| NCT02306460 | Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT02306460 | Recruiting | Tampere University Hospital | 2020-12-31 |
| NCT02306824 | Berlin Atrial Fibrillation Registry | https://ClinicalTrials.gov/show/NCT02306824 | Active, not recruiting | Charite University, Berlin, Germany | 2017-11-30 |
| NCT02252861 | French Database of Left Atrial Appendage Closure | https://ClinicalTrials.gov/show/NCT02252861 | Active, not recruiting | Henri Mondor University Hospital | 2019-09-30 |
| NCT02219984 | START-Register: Survey on Anticoagulated Patients Register | https://ClinicalTrials.gov/show/NCT02219984 | Recruiting | St. Orsola Hospital | 2023-07-31 |
| NCT02155907 | Atrial Fibrillation Detected by ELR and Holter Recording, a Comparison in Patients With Ischemic Stroke or TIA | https://ClinicalTrials.gov/show/NCT02155907 | Completed | University of Aarhus | 2017-12-31 |
| NCT02145858 | Prevention of Retained-Blood Outcomes With Active Clearance Technology | https://ClinicalTrials.gov/show/NCT02145858 | Completed | ClearFlow, Inc. | 2016-07-31 |
| NCT02032030 | Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys | https://ClinicalTrials.gov/show/NCT02032030 | Active, not recruiting | Washington University School of Medicine | 2020-07-31 |
| NCT02018497 | Essential Hypotension and Allostasis Registry | https://ClinicalTrials.gov/show/NCT02018497 | Recruiting | CES University | 2020-07-30 |
| NCT01972295 | Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry | https://ClinicalTrials.gov/show/NCT01972295 | Completed | Boston Scientific Corporation | 2018-01-23 |
| NCT01972282 | Registry on WATCHMAN Outcomes in Real-Life Utilization | https://ClinicalTrials.gov/show/NCT01972282 | Completed | Boston Scientific Corporation | 2015-11-30 |
| NCT01867099 | Ten-year Outcomes After AF Ablation | https://ClinicalTrials.gov/show/NCT01867099 | Completed | Valley Health System | 2012-12-31 |
| NCT01871194 | An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®). | https://ClinicalTrials.gov/show/NCT01871194 | Completed | Drug Safety Research Unit, Southampton, UK | 2016-01-31 |
| NCT01816308 | Cognitive Impairment in Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT01816308 | Recruiting | Texas Cardiac Arrhythmia Research Foundation | 2020-06-30 |
| NCT01796093 | Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function | https://ClinicalTrials.gov/show/NCT01796093 | Completed | Cocco, Giuseppe, M.D. | 2012-02-29 |
| NCT01786486 | AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol | https://ClinicalTrials.gov/show/NCT01786486 | Completed | Abbott Medical Devices | 2013-12-31 |
| NCT01774357 | Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems | https://ClinicalTrials.gov/show/NCT01774357 | Completed | Biotronik SE & Co. KG | 2018-09-30 |
| NCT01759225 | Registry of Cardiovascular Disease Patients | https://ClinicalTrials.gov/show/NCT01759225 | Enrolling by invitation | Maccabi Healthcare Services, Israel | 2100-12-31 |
| NCT02024230 | Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation | https://ClinicalTrials.gov/show/NCT02024230 | Recruiting | Fujita Health University | 2018-12-31 |
| NCT04435418 | Eliquis Acute Stroke Safety Evaluation | https://ClinicalTrials.gov/show/NCT04435418 | Completed | University of Alberta | 2019-09-09 |
| NCT04419012 | Polish Atrial Fibrillation (POL-AF) Registry | https://ClinicalTrials.gov/show/NCT04419012 | Active, not recruiting | Jan Kochanowski University | 2020-06-30 |
| NCT04375241 | Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older | https://ClinicalTrials.gov/show/NCT04375241 | Recruiting | Diagram B.V. | 2021-03-01 |
| NCT04347187 | REGistry of Long-term AnTithrombotic TherApy-2 | https://ClinicalTrials.gov/show/NCT04347187 | Recruiting | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 2025-12-31 |
| NCT04322474 | Russian National Registry of LAAO | https://ClinicalTrials.gov/show/NCT04322474 | Completed | National Research Center for Preventive Medicine | 2017-12-30 |
| NCT04315974 | Italian Registry In the Setting of AF Ablation With Rivaroxaban (IRIS) | https://ClinicalTrials.gov/show/NCT04315974 | Recruiting | Azienda Policlinico Umberto I | 2022-03-31 |
| NCT04307225 | Atrial Fibrillation After CABG and PCI | https://ClinicalTrials.gov/show/NCT04307225 | Recruiting | Region Örebro County | 2020-12-31 |
| NCT04222868 | Indonesian Registry on Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT04222868 | Recruiting | Indonesian Heart Rhythm Society | 2020-12-30 |
| NCT04195113 | Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry | https://ClinicalTrials.gov/show/NCT04195113 | Recruiting | McMaster University | 2022-08-31 |
| NCT04193813 | Predictors of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Prospective Cohort Study | https://ClinicalTrials.gov/show/NCT04193813 | Completed | Ain Shams University | 2019-03-18 |
| NCT04125641 | Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT04125641 | Recruiting | Yonsei University | 2022-08-31 |
| NCT04097132 | Pattern of Non Valvular Atrial Fibrillation in Acute Ischemic Stroke Patients at Assiut University Hospitals | https://ClinicalTrials.gov/show/NCT04097132 | Recruiting | Assiut University | 2021-01-01 |
| NCT04088071 | Registry for Real-world Experience of Catheter Ablation for Symptomatic Paroxysmal Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT04088071 | Enrolling by invitation | Heart Rhythm Clinical and Research Solutions, LLC | 2022-06-30 |
| NCT04085731 | Driver-guided Ablation of Persistent Atrial Fibrillatiom | https://ClinicalTrials.gov/show/NCT04085731 | Recruiting | IRCCS Policlinico S. Donato | 2021-09-21 |
| NCT04055961 | Atrial Fibrillation Ablation Registry | https://ClinicalTrials.gov/show/NCT04055961 | Recruiting | Hoag Memorial Hospital Presbyterian | 2025-05-20 |
| NCT04080830 | Registration Study of Acute Ischemic Stroke/Transient Ischemic Attack (TIA) With Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT04080830 | Recruiting | Xuanwu Hospital, Beijing | 2021-12-30 |
| NCT04042155 | Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD) | https://ClinicalTrials.gov/show/NCT04042155 | Recruiting | Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau | 2022-08-01 |
| NCT04024124 | A Ring-type Wearable Device for Atrial Fibrillation Among Ambulatory Patients | https://ClinicalTrials.gov/show/NCT04024124 | Recruiting | Seoul National University Hospital | 2023-08-31 |
| NCT04010955 | Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON) | https://ClinicalTrials.gov/show/NCT04010955 | Recruiting | Asan Medical Center | 2023-08-31 |
| NCT04023188 | A Ring-type Wearable Device for Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT04023188 | Active, not recruiting | Seoul National University Hospital | 2020-08-30 |
| NCT04022954 | HD Mapping of Atrial Fibrillation in Asia Pacific | https://ClinicalTrials.gov/show/NCT04022954 | Recruiting | Abbott Medical Devices | 2020-08-31 |
| NCT04005508 | OSA and CV Outcomes in Patients With High Risk AF | https://ClinicalTrials.gov/show/NCT04005508 | Recruiting | National University, Singapore | 2023-06-30 |
| NCT03963349 | THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study | https://ClinicalTrials.gov/show/NCT03963349 | Recruiting | Biosense Webster, Inc. | 2022-01-31 |
| NCT03847753 | Exploring the Comorbidity Between Mental Disorders and General Medical Conditions | https://ClinicalTrials.gov/show/NCT03847753 | Completed | University of Aarhus | 2016-12-31 |
| NCT03838341 | Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation. | https://ClinicalTrials.gov/show/NCT03838341 | Recruiting | Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland | 2020-12-31 |
| NCT03836339 | Assessment of Atrial Fibrillation in Emergency Department | https://ClinicalTrials.gov/show/NCT03836339 | Active, not recruiting | RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône | 2019-12-31 |
| NCT03818724 | Treatment Success With the CoolLoop Cryoablation System | https://ClinicalTrials.gov/show/NCT03818724 | Recruiting | AFreeze GmbH | 2025-01-31 |
| NCT03760705 | Singapore Cardiac Longitudinal Outcomes Database | https://ClinicalTrials.gov/show/NCT03760705 | Active, not recruiting | National Heart Centre Singapore | 2025-12-31 |
| NCT03737838 | Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF) | https://ClinicalTrials.gov/show/NCT03737838 | Recruiting | University of Chicago | 2020-11-30 |
| NCT03695484 | Registry Evaluating AF Ablation Techniques | https://ClinicalTrials.gov/show/NCT03695484 | Recruiting | Erasmus Medical Center | 2021-10-31 |
| NCT03653598 | BLITZ Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT03653598 | Completed | Heart Care Foundation | 2016-12-30 |
| NCT03656523 | Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI | https://ClinicalTrials.gov/show/NCT03656523 | Active, not recruiting | Heart Care Foundation | 2020-01-30 |
| NCT02270112 | Enhanced Diagnostics for Early Detection of Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT02270112 | Completed | University Hospital, Basel, Switzerland | 2015-10-31 |
| NCT03627806 | FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF) | https://ClinicalTrials.gov/show/NCT03627806 | Recruiting | University of Miami | 2021-01-31 |
| NCT03620656 | The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT03620656 | Completed | Qompium NV | 2019-07-01 |
| NCT03591627 | Left Atrial Thrombus on Transesophageal Echocardiography | https://ClinicalTrials.gov/show/NCT03591627 | Recruiting | Medical University of Warsaw | 2019-09-30 |
| NCT03589170 | ATRIAL FIBRILATION OPPORTUNISTIC SCREENING AND STROKE (AFOSS). | https://ClinicalTrials.gov/show/NCT03589170 | Active, not recruiting | Jordi Gol i Gurina Foundation | 2017-12-31 |
| NCT03546439 | VAscular Closure for Cardiac Ablation Registry (VACCAR) | https://ClinicalTrials.gov/show/NCT03546439 | Recruiting | Saint Luke’s Health System | 2020-10-31 |
| NCT03524924 | Edoxaban and Frailty in Senior Individuals | https://ClinicalTrials.gov/show/NCT03524924 | Completed | University of Padova | 2020-02-01 |
| NCT03505801 | Confirm Rx SMART Registry | https://ClinicalTrials.gov/show/NCT03505801 | Recruiting | Abbott Medical Devices | 2020-01-31 |
| NCT03491202 | The Genetic Basis for Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT03491202 | Recruiting | Jesse Brown VA Medical Center | 2022-05-31 |
| NCT03488420 | Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE | https://ClinicalTrials.gov/show/NCT03488420 | Recruiting | Montreal Heart Institute | 2021-03-01 |
| NCT03446794 | Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis | https://ClinicalTrials.gov/show/NCT03446794 | Recruiting | Fundación EPIC | 2021-03-01 |
| NCT03444259 | Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients | https://ClinicalTrials.gov/show/NCT03444259 | Recruiting | University of Turku | 2025-12-31 |
| NCT03436082 | Post-Market Surveillance With a Novel mHealth Platform | https://ClinicalTrials.gov/show/NCT03436082 | Completed | Yale University | 2018-12-25 |
| NCT03428048 | Cardiovascular Innovation & Research Institute ’s NEXUS Registry, the Whole is Greater Than the Parts. | https://ClinicalTrials.gov/show/NCT03428048 | Recruiting | Cardiovascular Innovation and Research Institute | 2026-03-31 |
| NCT03487419 | Echocardiographic Left Atrial Function Assessment and Atrial Fibrillation Post-Coronary Artery Bypass Surgery | https://ClinicalTrials.gov/show/NCT03487419 | Recruiting | National Heart Institute, Egypt | 2019-12-30 |
| NCT02362659 | Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry | https://ClinicalTrials.gov/show/NCT02362659 | Completed | Icahn School of Medicine at Mount Sinai | 2018-11-15 |
| NCT02401854 | Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder | https://ClinicalTrials.gov/show/NCT02401854 | Completed | Population Health Research Institute | 2015-03-31 |
| NCT02919982 | Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation | https://ClinicalTrials.gov/show/NCT02919982 | Active, not recruiting | Baim Institute for Clinical Research | 2018-05-31 |
| NCT02444221 | Rivaroxaban Evaluation in Real Life Settings | https://ClinicalTrials.gov/show/NCT02444221 | Active, not recruiting | Thrombosis Research Institute | 2019-05-31 |
| NCT04075084 | Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs) | https://ClinicalTrials.gov/show/NCT04075084 | Recruiting | Biotronik SE & Co. KG | 2021-10-31 |
| NCT03760874 | Atrial Fibrillation Research Database | https://ClinicalTrials.gov/show/NCT03760874 | Recruiting | University of Campania “Luigi Vanvitelli” | 2022-01-01 |